Ludo Van Den Bosch
Location
Region
flanders
Role
Co-founder
Company
LinkedIn
Expertise
biotech, neuroscience, drug-development
TLDR
Ludo Van Den Bosch is a co-founder of Augustine Therapeutics, a Belgian biotech developing treatments for neuromuscular and neurodegenerative diseases.
Overview
Co-founded Augustine Therapeutics alongside Bart De Strooper and Joris De Wit, researchers with strong academic credentials in neuroscience. The company raised EUR 77.7M in a Series A round in H1 2025, one of the larger biotech rounds in recent Belgian history, with PMV among the backers.
Connections
Co-founded Augustine Therapeutics alongside Bart De Strooper and Joris De Wit.